Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its primary product candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 3 clinical trial for the treatment of idiopathic pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas.

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare ...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2021-01-08	Premium	sold	Premium	Premium	Premium	-
2021-01-07	Premium	sold	Premium	Premium	Premium	-
2021-01-06	Premium	sold	Premium	Premium	Premium	-

LUMO - Lumos Pharma Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for LUMO